A meta-analysis of 814 patients with head and neck squamous cell carcinoma (HNSCC) showed a better objective response rate (ORR) and survival when treated with PD-1/PD-L1 inhibitors in HPV-positive tumours compared to HPV-negative tumours. Here, CD274 is linked to head and neck squamous cell carcinoma.